イリシンの悪性腫瘍における二重の役割と,バイオマーカーおよび治療標的としての可能性
Liqun Mo1,2, Xu Zeng1, Yu Liu1
1Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
Drug design, development and therapy
|August 27, 2025
まとめ
筋肉から分泌されるタンパク質であるアイリスンは ガンにおける二重の役割を示し 腫瘍を抑制し 肝臓がんなどの腫瘍を 促進します 癌の治療のための複雑な機能を理解するためにさらなる研究が必要です.
科学分野:
- 腫瘍学
- 分子生物学
- 内分泌学
背景:
- 骨格筋からのミオカインであるアイリスンは,様々な生理学的機能で認識されています.
- 新しい証拠は,がんのバイオマーカーと治療標的としてのアイリシンの可能性を示唆しています.
- 腫瘍形成におけるイリシンの役割を理解することは 新しいがん治療法の開発に不可欠です
研究 の 目的:
- 様々な癌に対するアイリシンの影響に関する現在の理解をレビューする.
- 重要な信号伝達経路を通じて 腫瘍形成を制御する イリシンの作用を探るため
- 異なった癌の種類における イリシンのパラドックスな役割を強調する
主な方法:
- 腫瘍学におけるアイリスンの研究を統合する文献レビュー.
- イリシンの信号伝達経路 (PI3K/AKT,AMPK-mTOR,STAT3/Snail) との相互作用の分析
- 癌細胞の増殖,移動,侵入におけるアイリシンの二重の役割の検討.
主要な成果:
- 肺,乳がん,臓がんの増殖と侵入を抑制する二重の役割を示しています.
- 対照的に,イリシンは肝細胞がんの進行を促すようです.
- 腫瘍の種類と内部の異なったアイリシン発現レベルが観察された.
結論:
- イリシンの機能の組織特異的な二分性は,治療上の課題を提示する.
- 腫瘍の微小環境におけるイリシンの文脈依存的な役割を明らかにするために,さらなるメカニズム研究が必要である.
- アイリシンの機能の明確化は 標的型がん治療の開発とバイオマーカーの有用性の改善に不可欠です
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


